Page last updated: 2024-08-17

carbostyril and Angiogenesis, Pathologic

carbostyril has been researched along with Angiogenesis, Pathologic in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's10 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, AT; Chan, SL; Hui, CW; Lau, CP; Lui, VW; Ma, BB; Wong, CH; Yeo, W; Zhou, Q1
Aparicio, A; Cao, X; Chinnaiyan, AM; Corn, PG; Efstathiou, E; Iyer, MK; Kundra, V; Li Ning Tapia, EM; Logothetis, CJ; McKeehan, W; Navone, NM; Palanisamy, N; Ravoori, MK; Robinson, DR; Starbuck, MW; Tapia, EM; Troncoso, P; Vazquez, ES; Wan, X; Wang, F; Wu, YM; Yang, J; Zurita, AJ1
Abdelhamid, IA; Ahmed, AG; Attia, YM; Ghozlan, SA; Mohamed, MF; Shouman, SA1
Akiel, MA; Biagi, JM; Christadore, LM; Fisher, PB; Gredler, R; Hansen, U; Jariwala, N; Rajasekaran, D; Robertson, CL; Sarkar, D; Schaus, SE; Shen, XN; Siddiq, A; Subler, MA; Willoughby, JL; Windle, JJ; Yunes, SA1
Desco, M; Hernández-Agudo, E; Hidalgo, M; Lopez-Casas, PP; Megías, D; Mondejar, T; Mouron, S; Mulero, F; Quintela-Fandino, M; Sanchez, J; Soto-Montenegro, ML1
Mabeta, P1
Auer, R; Mabeta, P; Mphahlele, MJ1
Bing, C; González-Muniesa, P; Trayhurn, P1
Doçi, CL; Hasina, R; Lingen, MW; Mankame, TP; Wroblewski, K; Zhou, G1
Becker, RE; Dalrymple, SL; DeWeese, TL; Isaacs, JT; Zhou, H1
Chen, ZY; Guo, RP; Guo, ZX; Li, SH; Li, XJ; Peng, LX; Qian, CN; Shi, M; Wei, W; Zhong, C1
Bonginelli, P; Capaccetti, B; Fanelli, M; Gasparini, G; Gattuso, D; Longo, R; Sarmiento, R1
Cohen-Jonathan, E; Delmas, C; End, D; Favre, G; Rochaix, P; Toulas, C1
Aukerman, SL; Garrett, E; Gelb, AB; Harris, A; Heise, C; Lee, SH; Lopes de Menezes, D; Nordahl, L; Samara, E; Vora, J; Ye, H1
Björk, A; Dalrymple, SL; Garrison, JB; Isaacs, JT; Kyprianou, N; Leanderson, T; Olsson, A; Pili, R; Qian, DZ1

Reviews

1 review(s) available for carbostyril and Angiogenesis, Pathologic

ArticleYear
[Innovative treatment in oncology].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:11

    Topics: Antibodies, Monoclonal; Humans; Neoplasms; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Quinolones

2002

Other Studies

14 other study(ies) available for carbostyril and Angiogenesis, Pathologic

ArticleYear
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Everolimus; Humans; Liver Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Quinolones; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2013
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.
    Science translational medicine, 2014, Sep-03, Volume: 6, Issue:252

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fibroblast Growth Factor 2; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neovascularization, Pathologic; Osteoblasts; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Stromal Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays

2014
Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-oxindole derivatives of 2-amino-tetrahydroquinolin-5-one.
    Archiv der Pharmazie, 2015, Volume: 348, Issue:2

    Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 9; Cell Proliferation; Disk Diffusion Antimicrobial Tests; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Design; Hep G2 Cells; Humans; Indoles; MCF-7 Cells; Molecular Structure; Neovascularization, Pathologic; Oxindoles; Quinolones; Signal Transduction; Structure-Activity Relationship; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2015
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
    Oncotarget, 2015, Sep-22, Volume: 6, Issue:28

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodioxoles; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Diethylnitrosamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Genes, myc; Genetic Predisposition to Disease; Humans; Liver Neoplasms, Experimental; Mice, Transgenic; Mitosis; Molecular Targeted Therapy; Neovascularization, Pathologic; Phenotype; Quinolones; Signal Transduction; Time Factors; Transcription Factors

2015
Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.
    Molecular oncology, 2016, Volume: 10, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Benzimidazoles; Breast; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Deoxycytidine; Female; Fluorine Radioisotopes; Gemcitabine; Humans; Mice; Mice, Nude; Misonidazole; Neovascularization, Pathologic; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Quinolones

2016
PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation.
    Acta pharmaceutica (Zagreb, Croatia), 2016, Sep-01, Volume: 66, Issue:3

    Topics: Animals; Antineoplastic Agents; Aorta; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Hemangioendothelioma; Male; Mice; Neoplasm Proteins; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Quinolones; Rats, Sprague-Dawley; Ribosomal Protein S6; Sulfones; Tissue Culture Techniques

2016
Evaluation of the antiangiogenic effects of 2-aryl-3-bromoquinolin-4(1H)-ones and a NCH3-4-oxo derivative.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Aorta; Cell Proliferation; Endothelial Cells; Humans; In Vitro Techniques; Male; Microvessels; Molecular Structure; Neovascularization, Pathologic; Quinolones; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2009
Upregulation of the expression of inflammatory and angiogenic markers in human adipocytes by a synthetic cannabinoid, JTE-907.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:10

    Topics: Adipocytes; Biomarkers; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Differentiation; Chemokine CCL2; Dioxoles; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1beta; Middle Aged; Neovascularization, Pathologic; Quinolones; Receptors, Cannabinoid; TRPV Cation Channels; Up-Regulation

2010
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:11

    Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Immunohistochemistry; Mice; Mice, Inbred CBA; Mouth Neoplasms; Neovascularization, Pathologic; Piperidines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor

2010
Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.
    The Prostate, 2012, May-01, Volume: 72, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Combined Modality Therapy; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Prostatic Neoplasms; Quinolines; Quinolones; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured

2012
Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.
    Journal of translational medicine, 2012, Dec-10, Volume: 10

    Topics: Animals; Apoptosis; Benzimidazoles; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Humans; Liver Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinolones; Receptor Protein-Tyrosine Kinases; Signal Transduction; Xenograft Model Antitumor Assays

2012
The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-01, Volume: 9, Issue:16 Pt 1

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Cell Hypoxia; Enzyme Inhibitors; Farnesyltranstransferase; Glioblastoma; Glioma; Humans; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neovascularization, Pathologic; Oxygen; Quinolones; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, May-15, Volume: 11, Issue:10

    Topics: Animals; Benzimidazoles; Biomarkers, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Growth Substances; Humans; Mice; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-sis; Quinolones; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-1

2005
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    The Prostate, 2006, Dec-01, Volume: 66, Issue:16

    Topics: Angiogenesis Inhibitors; Animals; Cell Growth Processes; Cell Line, Tumor; Dogs; Humans; Hydroxyquinolines; Male; Mice; Neovascularization, Pathologic; Prostatic Neoplasms; Quinolines; Quinolones; Rats; Xenograft Model Antitumor Assays

2006